Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Mar;89(3):307–314. doi: 10.1111/j.1349-7006.1998.tb00563.x

Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

Youichiro Noguchi 1, Jun Wu 1, Ruth Duncan 2, Jiří Strohalm 3, Karel Ulbrich 3, Takaaki Akaike 1, Hiroshi Maeda 1,✉
PMCID: PMC5921799  PMID: 9600125

Abstract

The objective of this study was to investigate the molecular weight (MW) and time‐dependence of the phenomenon termed “the enhanced permeability and retention”(EPR) effect in solid tumor, in particular to determine and define the early phase accumulation of macromolecules in tumor and normal tissues and the relationship between blood concentration and tissue clearance. As a model, radioiodinated N‐(2‐hydroxypropyl)methacrylamide (HPMA) copolymers of MW ranging from 4.5 K to 800 K were administered i.v. to mice bearing sarcoma 180 tumor. Within 10 min all HPMA copolymers accumulated effectively in the tumor regardless of MW (1.0–1.5% of injected dose per g of tumor). However, higher MW copolymers (>50 K) showed significantly increased tumor accumulation after 6 h, while the lower MW copolymers (<40 K) were cleared rapidly from tumor tissue due to rapid diffusion back into the bloodstream. Blood clearance was also MW‐dependent; the lower MW copolymers displayed rapid clearance, with kidney radioactivity of the copolymers of MW <20 K representing 24% of injected dose per g kidney at 1 min after i.v. administration. Within 10 min these copolymers passed through the kidney and were excreted in the urine. Higher MW copolymers consistently showed kidney levels of 3–5% dose per g kidney in the early phase with no time‐dependent accumulation in kidney. There was also no progressive accumulation in muscle or liver, regardless of polymer MW. These results suggest the “EPR effect” in solid tumor primarily arises from in the difference in clearance rate between the solid tumor and the normal tissues after initial penetration of the polymers into these tissues.

Keywords: Polymer drugs, Tumor targeting accumulation, EPR effect, Tumor vascular permeability, Tissue clearance

Full Text

The Full Text of this article is available as a PDF (117.1 KB).

REFERENCES

  • 1. ) Konno , T. , Maeda , H. , Iwai , K. , Tashiro , S. , Maki , S. , Morinaga , T. , Mochinaga , M. , Hiraoka , T. and Yokoyama , I.Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report . Eur. J. Cancer Clin. Oncol. , 19 , 1053 – 1065 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Iwai , K. , Maeda , H. and Konno , T.Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X‐ray image . Cancer Res. , 44 , 2115 – 2121 ( 1984. ). [PubMed] [Google Scholar]
  • 3. ) Konno , T. , Maeda , H. , Iwai , K. , Maki , S. , Tashiro , S. , Uchida , M. and Miyauchi , Y.Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium . Cancer , 54 , 2367 – 2374 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Iwai , K. , Maeda , H. , Konno , T. , Matsumura , Y. , Yamashita , R. , Yamasaki , K. , Hirayama , S. and Miyauchi , Y.Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver . Anticancer Res. , 7 , 321 – 328 ( 1987. ). [PubMed] [Google Scholar]
  • 5. ) Seymour , L. W. , Ulbrich , K. , Steyger , P. S. , Brereton , M. , Subr , V. , Strohalm , J. and Duncan , R.Tumour tropism and anticancer efficacy of polymer‐based doxorubicin prodrugs in the treatment of subcutaneous murine B16 F10 melanoma . Br. J. Cancer , 70 , 636 – 641 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Sinn , H. , Shrenk , H. H. , Fredrich , E. A. , Schilling , U. and Maier‐Borst , W. A. A.Design of compounds having an increased tumour uptake: using serum albumin as carrier. Part 1 . Nucl. Med. Biol. , 17 , 819 – 827 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Wu , N. Z. , Da , D. , Rudoll , T. L. , Needham , D. , Whorton , A. R. and Dewhirst , M. W.Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue . Cancer Res. , 53 , 3765 – 3770 ( 1993. ). [PubMed] [Google Scholar]
  • 8. ) Yuan , F. , Dellian , M. , Fukumura , D. , Leunig , M. , Berk , D. A. , Torchilin , V. P. and Jain , R. K.Vascular permeability in a human tumour xenograft: molecular size dependence and cutoff size . Cancer Res. , 55 , 3752 – 3756 ( 1995. ). [PubMed] [Google Scholar]
  • 9. ) Matsumura , Y. and Maeda , H.A new concept for macromolecular therapeutics in cancer therapy: mechanism of tumoritropic accumulation of proteins and the antitumor agents SMANCS . Cancer Res. , 46 : 6387 – 6392 ( 1986. ). [PubMed] [Google Scholar]
  • 10. ) Maeda , H. and Matsumura , Y.Tumoritropic and lymphotropic principles of macromolecular drugs . Crit. Rev. Ther. Drug Carrier Syst. , 6 , 193 – 210 ( 1989. ). [PubMed] [Google Scholar]
  • 11. ) Maeda , H.SMANCS and polymer‐conjugated macromolecular drugs: advantages in cancer chemotherapy . Adv. Drug Delivery Rev. , 6 , 181 – 202 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Seymour , L. W. , Miyamoto , Y. , Maeda , H. , Brereton , M. , Strohalm , J. , Ulbrich , K. and Duncan , R.Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier . Eur. J. Cancer , 31A , 766 – 770 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Li , C. J. , Miyamoto , Y. , Kojima , Y. and Maeda , H.Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure . Br. J. Cancer , 67 , 975 – 980 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Maeda , H. , Matsumura , Y. and Kato , H.Purification and identification of [hydroxypropyl3]bradykinin in ascitic fluid from a patient with gastric cancer . J. Biol. Chem. , 263 , 16051 – 16054 ( 1988. ). [PubMed] [Google Scholar]
  • 15. ) Matsumura , Y. , Kimura , M. , Yamamoto , T. and Maeda , H.Involvement of the kinin‐generating cascade in enhanced vascular permeability in tumor tissue . Jpn. J. Cancer Res. , 79 , 1327 – 1334 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Maeda , H. , Noguchi , Y. , Sato , K. and Akaike , T.Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both nitric oxide scavenger and nitric oxide synthase inhibitor . Jpn. J. Cancer Res. , 85 , 331 – 334 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. ) Doi , K. , Akaike , T. , Horie , H. , Noguchi , Y. , Fujii , S. , Beppu , T. , Ogawa , M. and Maeda , H.Excessive production of nitric oxide in rat solid tumor and its implications in rapid tumor growth . Cancer , 77 , 1598 – 1604 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Senger , D. R. , Galli , S. J. , Dvorak , A. M. , Perruzzi , C. A. , Harvey , V. S. and Dvorak , H. F.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid . Science , 219 , 983 – 985 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Leung , D. W. , Cachianes , G. , Kuang , W. J. , Goeddel , D. V. and Ferrara , N.Vascular endothelial growth factor is a secreted angiogenic mitogen . Science , 246 , 1306 – 1309 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Keck , P. J. , Hauser , S. D. , Krivi , G. , Sanzo , K. , Warren , T. , Feder , J. and Connolly , D. T.Vascular permeability factor, an endothelial cell mitogen related to PDGF . Science , 246 , 1309 – 1312 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Wu , J. , Akaike , T. and Maeda , H.Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and an nitric oxide scavenger . Cancer Res. , 58 , 159 – 165 ( 1998. ). [PubMed] [Google Scholar]
  • 22. ) Seymour , L. W. , Duncan , R. , Strohalm , J. and Kopecek , J.Effect of molecular weight of N‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal and intravenous administration to rats . J. Biomed. Mater. Res. , 21 , 1341 – 1358 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Vasey , P. A. , Duncan , R. , Twelves , C. , Kaye , S. B. , Strolin‐Benedetti , M. and Cassidy , J.Clinical and pharmacokinetic phase I study of PK1 (HPMA co‐polymer doxorubicin) . Ann. Oncol. , 7 , 97 ( 1996. ). [Google Scholar]
  • 24. ) Cassidy , J. , Duncan , R. , Morrison , G. J. , Strohalm , J. , Plocova , D. , Kopecek , J. and Kaye , S. B.Activity of N‐(2‐hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model . Biochem. Pharmacol. , 38 , 857 – 879 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Duncan , R. , Kopecek , J. , Rejmanova , P. and Lloyd , J. B.Targeting of N‐(2‐hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues . Biochim. Biophys. Acta , 755 , 518 – 521 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Cartlidge , S. A. , Duncan , R. , Lloyd , J. B. , Kopeckova‐Rejmanova , P. and Kopecek , J.Soluble, crosslinked N‐(2‐hydroxypropyl)methacrylamide copolymers as potential drug carriers. 3. Targeting by incorporation of galactosamine residues. Effect of route of administration . J. Controlled Rel. , 4 , 265 – 278 ( 1987. ). [Google Scholar]
  • 27. ) Maeda , H. , Seymour , L. W. and Miyamoto , Y.Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo . Bioconjugate Chem. , 3 , 351 – 362 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Duncan , R. , Dimitrijevic , S. and Evagorou , E. G.The role of polymer conjugates in the diagnosis and treatment of cancer . S.T.P. Pharma. Sci. , 6 , 237 – 263 ( 1996. ). [Google Scholar]
  • 29. ) Kimoto , A. , Kono , T. , Kawaguchi , T. , Miyauchi , Y. and Maeda , H.Antitumor effect of SMANCS on rat mammary tumor induced by 7,12‐dimethylbenz[a]anthracene . Cancer Res. , 52 , 1013 – 1017 ( 1992. ). [PubMed] [Google Scholar]
  • 30. ) Murakami , Y. , Tabata , Y. and Ikada , Y.Effect of the molecular weight of water‐soluble polymers on accumulation at a inflammatory site following intravenous injection . Drug Delivery , 3 , 231 – 238 ( 1996. ). [Google Scholar]
  • 31. ) Maeda , H. , Oda , T. , Matsumura , Y. and Kimura , M.Improvement of pharmacological properties of protein‐drugs by tailoring with synthetic polymers . J. Bioact. Compat. Polym. , 3 , 27 – 43 ( 1988. ). [Google Scholar]
  • 32. ) Kimura , N. T. , Taniguchi , S. , Aoki , K. and Baba , T.Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration . Cancer Res. , 40 , 2061 – 2068 ( 1980. ). [PubMed] [Google Scholar]
  • 33. ) Duncan , R. , Rejmanova , P. , Kopecek , J. and Lloyd , J. B.Pinocytic uptake and intracellular degradation of N‐(2‐hydroxypropyl)methacrylamide copolymers. A potential drug delivery system . Biochim. Biophys. Acta , 678 , 143 – 150 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Skinner , S. A. , Tutton , P. J. M. and O'Brien , P. E.Microvascular architecture of experimental colon tumors in the rats . Cancer Res. , 50 , 2411 – 2417 ( 1990. ). [PubMed] [Google Scholar]
  • 35. ) Suzuki , M. , Takahashi , T. and Sato , T.Medial regression and its functional significance in tumor‐supplying host arteries: a morphometric study of hepatic arteries in human liver with hepatocellular carcinoma . Cancer , 59 , 444 – 450 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Ettinghausen , S. E. , Puri , R. J. and Rosenberg , S. A.Increased vascular permeability in organs mediated by the systemic administration of lymphokine‐activated killer cells and recombinant interleukin‐2 in mice . J. Natl. Cancer Inst. , 80 , 177 – 187 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Kimura , M. , Konno , T. , Oda , T. , Maeda , H. and Miyauchi , Y.Intracavitary treatment of malignant ascitic carcinoma‐tosis with oily anticancer agents in rats . Anticancer Res. , 13 , 1287 – 1292 ( 1993. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES